Psychology
2025
David M. Compton
1 citation
Previous research has reported relationships between nightmares, including nightmare frequency and variables such as gender, cognition, sleep habits and quality, and beliefs about dreams and their meaning. Using a convenience sample of undergraduate and graduate students enrolled at a small Evangelical Christian university, a number of potential factors were examined for their respective...
Journal of Behavioral and Brain Science
2023
Melissa C. Selinger, David M. Compton, Hamilton Morris et al.
3 citations
The management of patients with concomitant chronic pain (CP) and Major Depressive Disorder (MDD) remains challenging for clinicians. Current chronic pharmacologic management is often unsuccessful, or has intolerable side effects to the patients. While not restricted to patients with chronic pain, these patients are often diagnosed with depression, presenting with symptoms such as poor mood,...
Journal of Behavioral and Brain Science
2021
Shannon O’brien, David M. Compton, Julianna M. Davis et al.
Traditionally, ketamine was considered useful as a dissociative anesthetic. More recently, ketamine has been examined for its effects as a fast-acting antidepressant, for treatment-resistant depression, and as a non-opiate treatment of chronic pain. Unfortunately, ketamine has enjoyed popularity as a recreational drug among both adolescents and young adults. While some research suggests the use...
Journal of Behavioral and Brain Science
2017
David M. Compton, Kerri L. Dietrich, Peniel Esquivel et al.
2 citations
A drug of abuse, Foxy or Methoxy Foxy gained popularity among recreational users as an alternative to MDMA (Ecstasy). Considerable research into the consequences of MDMA use is available, yet much remains unknown about the neurobiological consequences of Foxy use. In addition, research into the long-term neuropsychological repercussions associated with these two compounds remains incomplete....
Physiology & Behavior
May 3, 2011
David M. Compton, Kerri L. Dietrich, Melissa C. Selinger et al.
21 citations
Foxy or Methoxy Foxy (5-methoxy-N,N-di(iso)propyltryptamine hydrochloride; 5-MeO-DIPT) is rapidly gaining popularity among recreational users as a hallucinogenic "designer drug." Unfortunately, much remain unknown about the consequences of its use on neuropsychological development or behavior. During one of two adolescent periods, the rats were given repeated injections of 5 mg/kg or 20 mg/kg...
Psychological Reports
June 1, 2006
David M. Compton, Melissa C. Selinger, Erin K Testa et al.
16 citations
The hallucinogenic "designer drug" known as Foxy or Methoxy Foxy and formally know as 5-Methoxy-N,N-di(iso)propyltryptamine hydrochloride (5-MeO-DIPT) is rapidly gaining popularity among recreational users. However, little is known about the consequences of its use on neuropsychological development or behavior. During one of two adolescent periods, the rats were given repeated injections of...